CAR NK Cell Therapy for T Follicular Helper Cells

Cecile King

Cell Reports Medicine (Apr 2020)

CAR NK Cell Therapy for T Follicular Helper Cells

Cecile King

Affiliations

Cecile King: Department of Immunology, The Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, NSW 2010, Australia; St Vincent’s Clinical School, Department of Medicine, UNSW, Sydney, NSW 2010, Australia; Corresponding author

Journal volume & issue: Vol. 1, no. 1
p. 100009

Abstract

Read online

T follicular helper (TFH) cells are associated with the development of both autoimmune disease and T cell malignancies. In this issue, Reighard et al.,1 describe the design of PD-L1 chimeric antigen receptor (CAR) NK cells that effectively target and eliminate TFH cells.

Published in Cell Reports Medicine

ISSN: 2666-3791 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General)
Website: https://www.cell.com/cell-reports-medicine

About the journal